MedyMatch

MedyMatch Focuses on Developing AI and Machine Learning-Based Solutions to Enhance Healthcare Quality and Delivery, with the Ultimate Goal of Improving Outcomes and Reducing Costs. Its Initial Focus is on Brain Hemorrhage, as MedyMatch is Developing Tools to Help Doctors Identify and Rapidly Treat Stroke or Traumatic Brain Injury in Acute Situations. MedyMatch’s Software Uses Deep Learning, Patient Data, and Clinical Insights to Indicate Possible Bleeding Locations. MedyMatch Leverages Big Data and Artificial Intelligence to Predict Strokes. The Company Scans CT Patent Images and Compares Them with Thousands of CT Results from Other Patients. The Company’s Technology Enables it to Achieve Near Standard Deviation in CT Scans. The Company Claims that, in Some Cases, its Ability to Detect Irregular Data May Surpass Doctors’ Observations. MedyMatch’s System Also Provides Discoveries in 3D Brain Images, Allowing Doctors to Make More Informed Decisions.